STOCK TITAN

[6-K/A] Evaxion A/S Amended Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K/A
Rhea-AI Filing Summary

Evaxion A/S (EVAX) filed an amended Form 6-K to correct a prior press release. The amendment confirms the company will announce its business update and third quarter 2025 financial results on November 6, 2025.

The report states the corrected press release is furnished as Exhibit 99.1 and is incorporated by reference into Evaxion’s effective registration statements on Forms S-8, F-3, and F-1. No financial results or guidance are included in this update.

Evaxion A/S (EVAX) ha presentato un Form 6-K emendato per correggere un precedente comunicato stampa. La modifica conferma che l'azienda annuncerà il suo aggiornamento sull'attività e i risultati finanziari del terzo trimestre 2025 il 6 novembre 2025. Il rapporto indica che il comunicato stampa corretto è fornito come Allegato 99.1 ed è incorporato per riferimento nelle dichiarazioni di registrazione efficaci di Evaxion sui moduli S-8, F-3 e F-1. Nessun risultato finanziario o indicazione è incluso in questo aggiornamento.
Evaxion A/S (EVAX) presentó un Formulario 6-K enmendado para corregir un comunicado de prensa anterior. La enmienda confirma que la empresa anunciará su actualización comercial y los resultados financieros del tercer trimestre de 2025 el 6 de noviembre de 2025. El informe indica que el comunicado de prensa corregido se aporta como el Anexo 99.1 y se incorpora por referencia a las declaraciones de registro vigentes de Evaxion en los Formularios S-8, F-3 y F-1. No se incluyen resultados financieros ni orientación en esta actualización.
Evaxion A/S (EVAX)은 이전 보도자료를 정정하기 위한 수정된 Form 6-K를 제출했습니다. 수정안은 회사가 2025년 11월 6일에 비즈니스 업데이트 및 2025년 3분기 재무실적을 발표할 것임을 확인합니다. 보고서는 수정된 보도자료가 Exhibit 99.1로 제출되었으며 Evaxion의 Form S-8, F-3 및 F-1에 따른 유효 등록서에 참조로 포함된다고 명시합니다. 이 업데이트에는 재무 결과나 가이던스는 포함되어 있지 않습니다.
Evaxion A/S (EVAX) a déposé un formulaire 6-K amendé pour corriger un communiqué de presse précédent. L’amendement confirme que la société annoncera sa mise à jour commerciale et les résultats financiers du troisième trimestre 2025 le 6 novembre 2025. Le rapport indique que le communiqué de presse corrigé est déposé en tant que l’Exhibit 99.1 et est incorporé par référence dans les déclarations d’enregistrement effectives d’Evaxion sur les Formulaires S-8, F-3 et F-1. Aucune donnée financière ni guidance n’est inclus dans cette mise à jour.
Evaxion A/S (EVAX) hat ein geändertes Form 6-K eingereicht, um eine frühere Pressemitteilung zu korrigieren. Die Änderung bestätigt, dass das Unternehmen am 6. November 2025 sein Geschäftsupdate und die Finanzergebnisse des dritten Quartals 2025 bekannt geben wird. Der Bericht besagt, dass die korrigierte Pressemitteilung als Anhang 99.1 vorgelegt wird und durch Bezugnahme in Evaxions gültigen Registrierungsunterlagen auf Form S-8, F-3 und F-1 aufgenommen ist. In diesem Update sind keine finanziellen Ergebnisse oder Leitlinien enthalten.
قامت Evaxion A / S (EVAX) بتقديم Form 6-K المعدل لتصحيح بيان صحفي سابق. يؤكد التعديل أن الشركة ستعلن عن تحديث أعمالها ونتائجها المالية للربع الثالث من عام 2025 في 6 نوفمبر 2025. ويذكر التقرير أن البيان الصحفي المصحح مُرفق كالمُلحق 99.1 ومُدرج بالمرجع ضمن بيانات التسجيل الفعالة الخاصة بـ Evaxion في النماذج S-8 و F-3 و F-1. لا توجد نتائج مالية أو توجيهات مُدرجة في هذا التحديث.
Positive
  • None.
Negative
  • None.
Evaxion A/S (EVAX) ha presentato un Form 6-K emendato per correggere un precedente comunicato stampa. La modifica conferma che l'azienda annuncerà il suo aggiornamento sull'attività e i risultati finanziari del terzo trimestre 2025 il 6 novembre 2025. Il rapporto indica che il comunicato stampa corretto è fornito come Allegato 99.1 ed è incorporato per riferimento nelle dichiarazioni di registrazione efficaci di Evaxion sui moduli S-8, F-3 e F-1. Nessun risultato finanziario o indicazione è incluso in questo aggiornamento.
Evaxion A/S (EVAX) presentó un Formulario 6-K enmendado para corregir un comunicado de prensa anterior. La enmienda confirma que la empresa anunciará su actualización comercial y los resultados financieros del tercer trimestre de 2025 el 6 de noviembre de 2025. El informe indica que el comunicado de prensa corregido se aporta como el Anexo 99.1 y se incorpora por referencia a las declaraciones de registro vigentes de Evaxion en los Formularios S-8, F-3 y F-1. No se incluyen resultados financieros ni orientación en esta actualización.
Evaxion A/S (EVAX)은 이전 보도자료를 정정하기 위한 수정된 Form 6-K를 제출했습니다. 수정안은 회사가 2025년 11월 6일에 비즈니스 업데이트 및 2025년 3분기 재무실적을 발표할 것임을 확인합니다. 보고서는 수정된 보도자료가 Exhibit 99.1로 제출되었으며 Evaxion의 Form S-8, F-3 및 F-1에 따른 유효 등록서에 참조로 포함된다고 명시합니다. 이 업데이트에는 재무 결과나 가이던스는 포함되어 있지 않습니다.
Evaxion A/S (EVAX) a déposé un formulaire 6-K amendé pour corriger un communiqué de presse précédent. L’amendement confirme que la société annoncera sa mise à jour commerciale et les résultats financiers du troisième trimestre 2025 le 6 novembre 2025. Le rapport indique que le communiqué de presse corrigé est déposé en tant que l’Exhibit 99.1 et est incorporé par référence dans les déclarations d’enregistrement effectives d’Evaxion sur les Formulaires S-8, F-3 et F-1. Aucune donnée financière ni guidance n’est inclus dans cette mise à jour.
Evaxion A/S (EVAX) hat ein geändertes Form 6-K eingereicht, um eine frühere Pressemitteilung zu korrigieren. Die Änderung bestätigt, dass das Unternehmen am 6. November 2025 sein Geschäftsupdate und die Finanzergebnisse des dritten Quartals 2025 bekannt geben wird. Der Bericht besagt, dass die korrigierte Pressemitteilung als Anhang 99.1 vorgelegt wird und durch Bezugnahme in Evaxions gültigen Registrierungsunterlagen auf Form S-8, F-3 und F-1 aufgenommen ist. In diesem Update sind keine finanziellen Ergebnisse oder Leitlinien enthalten.
قامت Evaxion A / S (EVAX) بتقديم Form 6-K المعدل لتصحيح بيان صحفي سابق. يؤكد التعديل أن الشركة ستعلن عن تحديث أعمالها ونتائجها المالية للربع الثالث من عام 2025 في 6 نوفمبر 2025. ويذكر التقرير أن البيان الصحفي المصحح مُرفق كالمُلحق 99.1 ومُدرج بالمرجع ضمن بيانات التسجيل الفعالة الخاصة بـ Evaxion في النماذج S-8 و F-3 و F-1. لا توجد نتائج مالية أو توجيهات مُدرجة في هذا التحديث.
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K/A

Amendment No. 1

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number: 001-39950

Evaxion A/S
(Exact Name of Registrant as Specified in Its Charter)

Dr. Neergaards Vej 5f
DK-2970 Hoersholm
Denmark

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ X ]      Form 40-F [   ]


INCORPORATION BY REFERENCE

This report on Form 6-K shall be deemed to be incorporated by reference in Evaxion A/S’s registration statements on Form S-8 (File No. 333-255064), on Form F-3 (File No. 333-265132), on Form F-1, as amended (File No. 333-266050), Form F-1 (File No. 333-276505), Form F-1 (File No. 333-279153), Form F-1 (File No. 333-283304), and Form F-3 (File No. 333- 285778), including any prospectuses forming a part of such registration statements and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Explanatory Note

Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline.

Press Release

On October 31, 2025, Evaxion A/S (the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, issued a press release titled "Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025". A copy of the press release is furnished as Exhibit 99.1 to this report on Form 6-K.

Exhibits

Exhibit Number Description
   
99.1 Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

   Evaxion A/S
   (Registrant)
    
   
Date: October 31, 2025 By:/s/ Birgitte Rønø    
   Birgitte Rønø
   Interim Chief Executive Officer
   

FAQ

What did Evaxion (EVAX) change in this 6-K/A?

It corrected the date in a prior press release, confirming the business update and Q3 2025 financial results will be announced on November 6, 2025.

When will Evaxion announce Q3 2025 results?

Evaxion will announce its business update and third quarter 2025 financial results on November 6, 2025.

Which exhibit contains the corrected press release?

Exhibit 99.1 contains the corrected press release.

Are any financial results included in this filing?

No. The filing provides a date correction and furnishes the updated press release; it does not include financial results.

Which registration statements incorporate this 6-K by reference?

It is incorporated by reference into Evaxion’s Forms S-8, F-3, and multiple F-1 registration statements listed in the filing.

Who signed the amended report for Evaxion?

It was signed by Birgitte Rønø, Interim Chief Executive Officer, dated October 31, 2025.
Evaxion AS

NASDAQ:EVAX

EVAX Rankings

EVAX Latest News

EVAX Latest SEC Filings

EVAX Stock Data

45.64M
4.86M
23.07%
6.82%
1.91%
Biotechnology
Healthcare
Link
Denmark
Horsholm